Summary & Overview
HCPCS G9934: Documentation of Serrated Adenoma or Sessile Serrated Polyp
HCPCS Level II code G9934 denotes documentation that a detected neoplasm is diagnosed exclusively as a traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma. The code supports standardized reporting of serrated-pathway colorectal lesions identified on histopathology, which has implications for surveillance recommendations and clinical communication across providers. Nationally, consistent use of this HCPCS Level II code can improve clarity in pathology reporting and downstream care coordination.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical context and service setting, plus guidance on where this code fits in documentation workflows. The publication outlines common modifier usage and gaps in available taxonomy and diagnosis mappings when such data are not provided. It also summarizes related billing considerations for outpatient pathology and hospital-based pathology departments.
This piece delivers practical reference material for coding leads, billing managers, and pathology administrators seeking to understand the clinical meaning and billing placement of G9934 at a national level. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9934 documents that a detected neoplasm is diagnosed only as a traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma. This code captures pathology documentation clarifying that the lesion meets serrated pathway morphology rather than other neoplastic classifications.
-
Service type: Pathology/diagnostic histopathology documentation
-
Typical site of service: Outpatient pathology laboratory or hospital-based pathology department
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old undergoing colonoscopic evaluation for colorectal cancer screening or surveillance. During colonoscopy, a polypoid lesion is identified and removed or biopsied. Pathology reports specifically document that the neoplasm meets criteria for a serrated pathway lesion and is diagnosed only as a traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma without invasive carcinoma. The clinical workflow includes endoscopic detection, polypectomy (snare or cold forceps), specimen submission to surgical pathology with clear clinical history, pathologic diagnosis confirming serrated lesion subtype, and documentation in the medical record to support use of the HCPCS Level II code G9934 indicating the neoplasm detected is only one of these serrated lesions. Typical site of service is an ambulatory endoscopy center or hospital outpatient department. Common patient follow-up includes surveillance interval determination based on lesion size, histology, and number of serrated lesions documented in the pathology report.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work required is substantially greater than typical for polypectomy or biopsy (rare for routine serrated lesion removal). |